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Use of natural immunity for controlling red mark 
syndrome in farmed rainbow trout 
As the name suggests, red mark syndrome (RMS) is a disease that causes red wound-like marks on 
farmed rainbow trout. The disease does not kill the fish, but makes them less attractive for human 
consumption and thus lowers their value. 
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Photo: Jakob Günther Schmidt. A rainbow trout with two large and a few smaller prototypical red mark syndrome 
lesions. 
RMS is a relatively benign disease, as it is usually not associated with mortality. Nonetheless, for some 
fish farmers RMS is very problematic due to the appearance of conspicuous large red skin marks.  
Usually, RMS affects large fish, often when ready for the market. Although the disease in most cases 
does not affect the muscle to any significant extent and the sensory and nutritional quality of the meat 
therefore is unaffected, the fish do not look very appetizing. 
Management challenges and loss of value 
This is not a problem if the fish are used for filets, fish cakes or similar processed products. However, 
the majority of the Danish rainbow trout production is of high quality and is sold as whole fish, and here 
the red marks result in downgrading and thus become a serious problem for the farmers who is left with 
the options of 1) either accepting a reduced price or 2) keeping the affected fish until the disease 
symptoms disappear.  
The latter leads to management challenges as it disrupts the planned flow of fish on the farm. On top of 
this put consumer dissatisfaction and loss of market shares. 
Experiments at DTU have shown that the red marks, depending on water temperature, may be present 
on the fish for several weeks. Red mark syndrome is a cold-water disease, and symptoms are generally 
not observed above 16°C. At 12°C it takes about a month from early appearance of the marks until they 
start to heal. Even then, lack of scales at the affected sites influences the perception of quality. The 
scales do regenerate after the inflammation is resolved, but this may take several weeks (see figure 2). 
 
Figure 2. Images showing the typical progression (from left to right) of an RMS lesion. The fish in the 
images was kept at 12°C. At this temperature the first early symptoms typically appear after 6-7 
weeks, then get progressively more severe over the next 4 weeks after which healing starts. 
All together the effects of RMS may be visible on the fish for several months. On top of that, the disease 
usually does not affect all the fish in the pond or raceway simultaneously, and may thus affect a cohort 
of fish for many months. 
A long way to go with vaccines 
Vaccines have been developed to tackle a number of fish diseases. However, no vaccines exist for red 
mark syndrome. In order to produce a vaccine against a disease, the organism causing the disease needs 
to be isolated and characterized.  
Although we are getting more and more confident that the disease is caused by a bacterium, which we 
provisionally call Midichloria-like organism (MLO), we only know the bacterium from a short piece of 
its DNA. We can detect this genetic “footprint” in fish affected by red mark syndrome, but more 
information is needed for vaccine production, and we have not been successful in isolating and 
culturing the bacterium. We thus have to look into other preventive strategies for RMS.  
Antibiotics are not the answer 
We have previously shown that RMS can be treated with antibiotics. However, there are several 
problems with this approach. Firstly, the use of antibiotics should be a last option in order to avoid the 
development of antimicrobial resistance. Secondly, in organic trout farming the use of antibiotics is 
restricted by the legislation.  Thirdly, the disease is not lethal and even does not seem to affect the 
welfare of the fish to a large extent as no changes in behaviour are observed in affected fish. Since 
antibiotics should be used to avoid pain, suffering and even death, it is ethically difficult to argue for the 
use of antibiotics for treatment or prevention of RMS. 
Finally, antibiotics are usually given in-feed for ten days, after which there is a retention period of 500 
degree-days (i.e. the water temperature in centigrade multiplied by the number of days must be at least 
500) before the fish can be sold for consumption. Thus, depending on the water temperature this 
approach may take a couple of months, and thus there may be only marginal benefits compared to 
letting the disease run its course. Hence, treatment with antibiotics is not a good option either.  
Natural immunity as control of RMS 
Since the behaviour and welfare of the fish appears relatively unaffected by the disease we wondered 
whether an option could be to deliberately expose the fish to RMS at a young age in order to establish 
natural immunity against later outbreaks. You can compare it with taking your toddler to visit a friend 
with chickenpox – just to get it over with and establish immunity before adulthood, where the 
implications of the disease are more severe. Such an approach was previously common in fish farming, 
even for more serious diseases where mortality in smaller, less valuable fish was preferred over risking 
loss of large valuable fish at a later stage. 
In collaboration with fish farmers, we established that the optimal time to infect the fish would be when 
the fish were moved to ponds or raceways for on-growing – typically at a size of 5-50g. 
Promising results: 
For this approach to work as intended we firstly needed to consider unknown properties of red mark 
syndrome: 
First of all we did not know if fish of 5-50g could get the disease, as this had never been reported. 
Conversely, it was important to establish that the disease did not affect the small fish too much. 
Secondly, it was essential to determine whether the fish would mount a long lasting immune response 
preventing RMS throughout the remainder of the production cycle. As humans, if we are sick with a 
given disease or if we are vaccinated against one, we expect our immune system to protect us from 
reinfection for years or even for our entire life. Although the immune system of a rainbow trout does not 
differ that much from ours, fish do not always produce robust and lasting adaptive immune responses 
the way humans do – especially not if they are infected or vaccinated at early life-stages.  
Most of the trout produced in Denmark are sold as portion-sized trout of typically 3-500g. This size is 
typically reached after 6-9 months. We thus needed to show that the early induction of RMS would 
protect the fish from re-infection for at least 9 months. To be on the safe side we waited a whole year 
before we re-exposed our fish to red mark syndrome.  
So far, we have successfully infected fingerlings: The fish did get the prototypical red marks of RMS 
without associated mortality. So, we could tick the first of our two prerequisites. ShelterFish has re-
exposed the fish along with similar control fish, which have never encountered RMS.  
So far, the results indicate that the pre-exposed fish apparently do not get RMS a second time. In 
case the on-going analyses support these observations, the next step is to develop a strategy for 
efficient implementation into practice on the trout farms. 
 
